- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- AHA: Cyber resilience critical to prevent nation-state hacks
- Elevance senior executive fights DOJ deposition bid in Medicare Advantage fraud case
- A split is emerging in healthcare’s workforce pipeline
- The hospitals, health systems cutting jobs in 2026
- 19 women making moves in healthcare
- Judy Faulkner’s long game: An Epic that no one can buy
- Why WakeMed’s CEO says his system will ‘survive’ but not ‘thrive’ alone
- NYC invests $12M in overdose recovery workforce
- Epic’s biggest moves in 2026 so far
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Providence raises $500M in philanthropy in 2025
- New York system opens outpatient pavilion
- ‘We cannot cut our way to success’: Hospitals prep for Medicaid crunch
- What cardiology ASCs still haven’t mastered
- Texas dental practice relocates into 6K-square-foot facility
- Surgery Partners opens 9 ASCs in 12 months amid ‘fickle’ M&A market
- Medit launches global orthodontics division, acquires California training institute
- What’s going on behind ASC de novo development?
- Pennsylvania enacts dental faculty bill
- Payer denials remain elevated, but aren’t accelerating: Tenet
- Dental industry eyes increased payer oversight, transparency: 4 updates
- Dr. Michael Durbin named president of the American Association of Orthodontists
- Arkansas dental school launches partnership with children’s hospital
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- Woodside Health acquires 40K-square-foot MOB
- Remarks at the 13th Annual Conference on Financial Market Regulation
- Eko Health appoints cardiologist as chief medical officer
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- North Carolina physician practice acquired
- Straine Dental unifies 3 operating companies under single brand
- Thomas Jefferson University to launch new nurse anesthesia program
- Inside this state’s ‘evolving’ noncompete policy
- Is dentistry losing its spark?
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’ for hospital medicine
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Wisconsin releases statewide mental health action plan: 4 things to know
- Nebraska Medicaid patients struggle to access care as dentists drop out: 6 notes
- Alabama behavioral health provider opens outpatient clinic
- Oscar Health's profit hits $679M, membership rises in Q1
- Kaiser Permanente eases ‘last mile to licensure’ for mental health workers
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- Cannabis most commonly microdosed substance in US: Study
- FDA Authorizes Fruit-Flavored Vapes for Adults
- White House outlines drug control strategy: What healthcare leaders should know
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- Touting $529B in savings over 10 years, White House looks to expand MFN deals with pharma
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Inside the gaps in fertility and surrogacy systems
- Lilly to invest $4.5B more into massive Indiana manufacturing complex
- CVS execs say company on track to meet MA margin goals by 2028
- Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- California hospitals sue Anthem over out-of-network care policy
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- UnitedHealthcare to reduce prior auth requirements by 30%
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- Pfizer delivers strong Q1 but keeps guidance steady amid COVID seasonality
- CVS to expand biosimilar formulary adoptions to improve affordability, accessibility
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Novartis to close German manufacturing site, cutting 220 jobs
- BioNTech to slash 1,860 jobs, exit sites in Germany and Singapore in major manufacturing pullback
- After Alzheimer's agitation nod, Axsome jacks up Auvelity's peak sales projection to $8B
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- Sanofi expands AI capabilities, investing $294M to scale Toronto hub
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Assort Health rolls out outbound AI agent for personalized patient outreach
- Neurocrine cites work disruption data to make case for timely movement disorder diagnosis
- Eyeing CAR-T autoimmune first, Kyverna hires pharma veteran as CCO
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial
- Prolific Machines sets monoclonal antibody manufacturing record with light-controlled platform
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
- She Survived 2 Shootings. Research Helps Explain Why Her Pain Persists Years Later.
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
- High-Intensity Exercise After Breast Cancer Surgery Helps Speed Recovery
- Trump Offers Third Candidate For Surgeon General After Pulling Dr. Casey Means' Nomination
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- Johnson & Johnson Enters Agreement to Acquire Atraverse Medical
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- enVVeno Medical Receives FDA IDE Approval for Non-Surgical Replacement Venous Valve
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Gains CE Mark for Stealth AXiS surgical system
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
- Medtronic Continues Cardiovascular Care Growth with Completion of CathWorks Acquisition
Clearly the ideology dies hard with this administration, but today's bulletin leaves many questions unanswered.
ACIP's actual recommendations are just four weeks old.
- That the CDC promote six risks and uncertainties;
- that patients should be informed of the risks of COVID-19 and its vaccination before receiving the shot;
- and that coronavirus vaccinations for all people should be based on “individual-based decision making.”
None of them are mentioned here.
Does this make DIFS noncompliant? Does it open Michigan to federal penalties or legal challenges?
What exactly are the "barriers" removed? Do they continue to block other medications from patient use and coverage? If the barriers aren't necessary for the COVID vaccine(s), why are they necessary for other care and treatment?
Will the state be compliant with this bulletin, or with ACIP, in its Medicaid program?
Hot links available in the DIFS presser.
DIFS Issues Bulletin to Ensure Michiganders Continue to Have Insurance Coverage for No-Cost COVID-19 Vaccines
Media Contact: DIFS-press@michigan.gov
Consumer Hotline: 877-999-6442, Michigan.gov/DIFScomplaintsFOR IMMEDIATE RELEASE: October 16, 2025
(LANSING, MICH) In response to Gov. Gretchen Whitmer’s Executive Directive, the Michigan Department of Insurance and Financial Services (DIFS) has issued a bulletin to ensure Michiganders continue to have health insurance coverage for no-cost COVID-19 vaccines. The bulletin reminds health insurers that plans in the individual and small group markets are required to continue to cover COVID-19 vaccines at no cost to consumers.
“Michiganders deserve access and coverage for COVID-19 vaccines, which is why I directed state departments to remove unnecessary barriers to ensure the COVID-19 vaccine is available to for Michiganders,” said Governor Whitmer. “According to medical experts, vaccines remain the safest and most effective way to stay healthy during this upcoming cold and flu season. I’m committed to providing Michiganders with the best options for staying safe and healthy.”
"Governor Whitmer’s Executive Directive is clear: we must ensure that vaccines remain available to Michiganders who want them so they can protect themselves and their loved ones,” said Director Fox. “Many insurers have already committed to continuing this vital coverage for COVID-19 vaccines, and today’s bulletin is another way to clear barriers and protect consumers. DIFS is prepared to assist consumers with any questions or concerns about their health insurance. Our live call center is available Monday through Friday, from 8 a.m. to 5 p.m., at 877-999-6442.”
The bulletin advises insurers in both the individual and small group markets that they are required to provide no-cost coverage for immunizations if the federal Advisory Committee on Immunization Practices (ACIP) includes the immunization in its recommendations. The ACIP continues to recommend the COVID-19 vaccine.
Consumers with questions about health insurance coverage for vaccines should contact their insurance company. If they cannot get the information they need or have additional questions, they should contact DIFS for assistance from 8 a.m. to 5 p.m. Monday through Friday at 877-999-6442. More information about health insurance coverages can be found at Michigan.gov/HealthInsurance.
....
It's always easy to offer gifts paid for by others.
Wednesday's provider bulletin expands on state COVID-19 vaccine requirements, continuing to minimize federal policy changes.
Sent by MDHHS, while looping in all health-related Michigan departments.
COVID-19 Vaccine Recommendations for Michigan
Public Health Bulletin for Health Care Providers - October 2025
Dear colleagues,As health care providers, you are among our most trusted voices in encouraging vaccine uptake and protecting Michigan communities.
This fall, we want to reinforce that 2025-26 COVID-19 vaccines are available statewide, and that they are critical in preventing severe health outcomes and deaths from COVID-19 infections.
Gov. Gretchen Whitmer’s Executive Directive 2025-7 and the Chief Medical Executive’s (CME) Standing Recommendation 2025-01 on COVID-19 vaccination were issued to remove barriers to accessing COVID-19 vaccines and to help ensure that all who want to get a COVID-19 vaccine can receive one.
The Standing Recommendation states that any person over the age of 6 months without contraindication who has not received a dose of a U.S. Food and Drug Administration (FDA)-approved or -authorized 2025-2026 COVID-19 vaccine may be considered to have an underlying condition that puts them at high risk for severe outcomes from COVID-19 and is thus eligible to receive an age-appropriate dose without additional barriers.
Michigan Department of Health and Human Services (MDHHS) COVID-19 vaccine guidance aligns with leading national medical organizations, including the American Academy of Pediatrics, American College of Obstetricians and Gynecologists, American Academy of Family Physicians and the American College of Physicians. Key Michigan medical groups also support this guidance. For patient-facing materials and other resources, including a COVID-19 vaccine FAQ, visit Michigan.gov/COVIDFluRSV.
Together, we can prevent illness, save lives and protect the health of our state. Thank you for continued work and partnership.
Sincerely,
Natasha Bagdasarian, MD, MPH, FIDSA, FACP
Chief Medical Executive, State of MichiganSarah Lyon Callo, MS, PhD
Senior Deputy Director and State Epidemiologist, MDHHS Public Health AdministrationInsurance coverage
COVID-19 vaccines remain available at no cost to most Michigan residents. Under Executive Directive 2025-7, MDHHS and the Michigan Department of Insurance and Financial Services (DIFS) are working to ensure that coverage under state-regulated health plans — including Medicaid and commercial insurance — continue to provide coverage.At the national level, America’s Health Insurance Plans reaffirmed in September that member plans will cover all immunizations that were recommended by the Advisory Committee on Immunization Practices as of Sept. 1, including COVID-19 and influenza vaccines, at no cost-sharing for patients through the end of 2026. This commitment provides stability for providers and reassurance for patients who may otherwise be concerned with cost.
At the state level, if patients do experience coverage denials or unexpected copays, encourage them to contact their health insurer directly. DIFS is also prepared to assist consumers with questions or concerns about their health insurance. Their call center is available Monday through Friday from 8 a.m. to 5 p.m., at 877-999-6442.
Licensee support
Michigan has taken steps to ensure that providers and pharmacists have the authority and protection needed to administer COVID-19 vaccines under the standing recommendation.Michigan Department of Licensing and Regulatory Affairs (LARA) reminds licensed health professionals that Michigan law authorizes them to administer the COVID-19 vaccine to any individual — including those outside the FDA-approved categories — if that professional is doing so under the direction of a physician. This authority also applies to pharmacists who have a collaborative-practice agreement with a prescriber.
LARA also notes that the CME Standing Recommendation 2025-01 will be taken into consideration should LARA receive a complaint against a health professional regarding the administration of this vaccine.
Provider action steps
We encourage you to take these steps to increase vaccine uptake among your patients:Review CME Standing Recommendation 2025-01 and update internal protocols to reflect universal COVID-19 vaccine eligibility for all patients 6 months and older.
A patient’s statement that they have not yet received the 2025-26 COVID-19 vaccine is sufficient to determine eligibility.
Continue to counsel patients on the benefits and risks of vaccination.
Co-administer COVID-19 vaccines with other routine vaccines, including influenza and RSV vaccines where appropriate – to maximize uptake and reduce missed opportunities.
Provide staff education so that nurses, medical assistants and front-line personnel can confidently answer patient questions.
Monitor insurance coverage challenges and report recurring patterns of denial or copays to MDHHS or DIFS.
Consider becoming a Vaccines for Children (VFC) provider. The pediatric COVID-19 vaccine is available to order through VFC and MDHHS strongly encourages all enrolled providers to carry it.
Additionally, please join the Michigan State Medical Society on Tuesday, Nov. 4, from 12 to 12:45 p.m., to hear a vaccine update from Dr. Natasha Bagdasarian. Dr. Bagdasarian will cover the latest developments, recommendations and public health strategies surrounding key vaccines. Any health care provider in Michigan may register for this free event.2025-2026 COVID-19 Vaccine – Provider FAQ
Why was CME Standing Recommendation 2025-01 issued? CME Standing Recommendation 2025-01 was issued to provide clarity for both patients and providers, and to remove barriers to vaccine access. If an individual has not yet received the 2025-26 COVID-19 vaccine, they may consider themselves high risk when answering screening questions at their pharmacy, provider’s office or local health department. This approach ensures broad eligibility while allowing health care providers to follow MDHHS’ guidance and remain consistent with updated FDA label language.How should I document eligibility in my electronic health record (EHR) or on screening forms? It will depend on your specific EHR or screening and/or intake forms. To remain consistent, record that the patient has not received a 2025-26 COVID-19 vaccine and add a brief note that eligibility is determined under the CME Standing Recommendation 2025-01.
How should insurance coverage work? The COVID-19 vaccine is covered at no cost for most Michigan residents. Medicaid, Medicare and most commercial insurance plans cover the vaccine. Nationally, health insurers have reaffirmed that they are committed to ensuring no-cost coverage. If a patient is billed unexpectedly, instruct them to contact their plan. DIFS is also prepared to assist consumers with questions or concerns about their health insurance. Their call center is available Monday through Friday from 8 a.m. to 5 p.m., at 877-999-6442.
What liability protections are in place for providers administering COVID-19 vaccines under the standing recommendation? LARA has confirmed that the CME Standing Recommendation 2025-01 will be considered in oversight and complaint review. Providers acting within the scope of the recommendation and their license/scope of practice have regulatory support to vaccinate eligible patients.
What is the process for reporting vaccine administration in the Michigan Care Improvement Registry (MCIR)? As you do for all other routine vaccines, health care providers must report in MCIR all immunizations administered to every child born after Dec. 31, 1993, and under 20 years of age within 72 hours of administration and ideally within the same timeframe for all other adults. Confirm that your EHR interface is sending successfully.
How can I help reduce barriers to vaccine uptake in my practice? Offer COVID-19 vaccination at every eligible visit and co-administer with other routine vaccines, including with flu and RSV vaccines when appropriate. Use clear eligibility messaging and send out reminders to any under-vaccinated groups that you serve. Ensure that staff are prepared to answer common questions and track any recurring insurance coverage issues to share with MDHHS or DIFS.
Who can participate in shared clinical decision-making for vaccines? Primary care physicians, specialist physicians, physician assistants, nurse practitioners, registered nurses and pharmacists can practice shared clinical decision-making. These types of discussions on benefits and risks already occur in most clinical interactions, e.g. providing vaccine information sheets and asking if the patient or guardian has any questions.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















